Jefferies raises Tilray stock price target on brewing restructuring

Jefferies raised its Tilray price target to $13 from $12 but maintained a Reduce rating; shares were $2.67, down 80% over the past year and near their 52-week low. Tilray plans to reduce its U.S. brewing facilities from 10 to 6, targeting about $20 million in annual savings by fiscal 2028, while Carlsberg is expected to add 8%–10% to beverage volume beginning in January. Recent fiscal Q1 2027 revenue rose 23% to $257.1 million, but Tilray reported a $40 million net loss.

Analysis

The restructuring is an execution test, not yet a valuation catalyst. Consolidating capacity can improve utilization and fixed-cost absorption, but the stated savings arrive only by FY28; weak beer volumes or operational disruption could absorb them. The proposed Carlsberg volume is potentially more important than the savings if it fills otherwise underused facilities, but it is a customer/volume dependency rather than proof of durable demand. Verify start timing, contract economics, and whether volume is incremental before capitalizing it.

The key tension is growth without demonstrated earnings conversion: reported revenue and gross-profit gains coexist with a net loss, while the cited EBITDA multiple is elevated. For TLRY, the near-term test is cash conversion and adjusted EBITDA—not top-line growth alone. A soft category backdrop also limits the likelihood that industry demand rescues underutilized capacity; established brewers such as Constellation Brands and Boston Beer face that volume headwind too, but Tilray’s restructuring makes execution risk more company-specific.

The analyst details are internally inconsistent: the item says Jefferies maintained Reduce, then later describes a Buy rating on Tilray. Do not trade the target-price change until the original note and rating are reconciled; the quoted target is particularly unreliable as an anchor against the stated market price. Over 1–3 months, watch reported beverage volume, facility closure costs, and guidance. Over 6–18 months, thesis confirmation requires savings to appear in EBITDA and cash flow without losing volume. Falsifiers: Carlsberg volume delayed or below expectations, continued negative cash conversion, or EBITDA guidance cuts.

Key Decisions for Investors

• No immediate directional position in TLRY on this note alone. Treat the rating/target inconsistency as a source-quality issue and verify Jefferies’ original research before using it.
• Keep TLRY on a proof-of-execution watchlist; consider entry only after a report demonstrates beverage-volume retention, lower operating costs, and improved cash conversion. Avoid valuing the full FY28 savings ahead of delivery.
• For an existing long, use the next earnings release as a risk checkpoint: reduce exposure if beverage guidance weakens, closure costs persist, or adjusted EBITDA fails to translate into cash flow.
• Monitor Constellation Brands and Boston Beer as category-volume indicators, not automatic hedges: their broader business mixes differ, so a relative-value position needs segment-level exposure and valuation checks.